Cytori Therapeutics, (CYTX) Posts Q4 Loss of 12, Wider than Views
Get Alerts CYTX Hot Sheet
Price: $0.21 --0%
Financial Fact:
Research and development: 2.86M
Today's EPS Names:
SYBX, DSGN, ATRA, More
Financial Fact:
Research and development: 2.86M
Today's EPS Names:
SYBX, DSGN, ATRA, More
Join SI Premium – FREE
Cytori Therapeutics, Inc. (NASDAQ: CYTX) reported Q4 EPS of ($0.12), $0.02 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $2.08 million versus the consensus estimate of $3.7 million.
For earnings history and earnings-related data on Cytori Therapeutics, Inc. (CYTX) click here.
For earnings history and earnings-related data on Cytori Therapeutics, Inc. (CYTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi Trends (CTRN) Misses Q4 EPS by 27c, Misses on Revenue; Offers Guidance
- Brenmiller Energy (BNRG) Issues 2023 Operational Update
- XPeng (XPEV) posts better-than-expected earnings, margin for Q4; stock climbs
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!